Missed Opportunities
March 27, 2019
Hepatitis C Screening Can Help Prevent Liver Disease 
March 28, 2019
Show all

Cardiovascular Risk Higher Among Black Patients With Rheumatoid Arthritis 

Researchers found that data showed that a high percentage of black patients with rheumatoid arthritis had a cardiovascular disease factor and that about half had specific rheumatoid arthritis risk factors, such as joint erosions, elevated inflammatory markers, extra-articular disease, and body mass indexes below 20, which requires effective intervention.

Black individuals with rheumatoid arthritis are more likely to have increased rates of cardiovascular risk factors than white individuals, according to a study recently published in Medical Sciences. These risk factors include dyslipidemia, hypertension, diabetes, and obesity. Data underscore the vulnerability of this population and the resultant need for stratified risk management.

This study included 503 individuals with rheumatoid arthritis, 88.5% of whom were black, 29.4% of whom were smokers, and 87.9% of whom were women. All patients were at least 18 years old and seen between 2010 and 2017. Physicians’ notes on consultations, inpatient/outpatient records, and the use of disease-modifying antirheumatic drugs were collected. A musculoskeletal radiologist viewing bilateral hand radiographs was blinded to the individual’s serologic status. To investigate variation in cardiovascular disease outcomes and risk profiles, therapeutic patterns, and features of rheumatoid arthritis disease acuteness, the largely black population was compared with the largely white population of the Consortium of Rheumatology Researchers of North America (CORRONA). Continuous variables were compared between groups using a t-test, whereas a χ2 test was used for categorical variable comparison.

Read on: Cardiovascular Risk Higher Among Black Patients With Rheumatoid Arthritis

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.